IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer
Last Thursday, April 11, another edition of IDIBELL PhD day took place in IDIBELL in the Duran i Reynals Hospital.
Researchers of the Bellvitge Biomedical Research Institute (IDIBELL) led by Dr. Montse Olivé have described in Nature Communications a new muscular disease caused by a mutation in the myoglobin gene.
The event gathered the main innovation experts in Catalonia and analyzed the synergies with the same industry in the United Kingdom
More sensitivity is not always better.